Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Polynovo Limited ( (AU:PNV) ) has provided an update.
PolyNovo Limited has announced the resignation of Mr. Lior Harel from his role as General Counsel and Company Secretary, effective April 15, 2025, as he pursues other opportunities. The responsibilities will be temporarily taken over by CFO Jan-Marcel Gielen until a replacement is appointed, indicating a seamless transition in leadership roles within the company.
More about Polynovo Limited
PolyNovo is a Melbourne-based medical technology company that specializes in products for managing acute complex wounds, offering innovative solutions with differentiated patient outcomes. The company has treated over 70,000 patients in 46 countries and is expanding through new products and markets.
YTD Price Performance: -36.54%
Average Trading Volume: 4,686
Technical Sentiment Signal: Strong Buy
Current Market Cap: $451.8M
Find detailed analytics on PNV stock on TipRanks’ Stock Analysis page.